u/Get_rch_or_try_dyin

Reddit r/pennystocks
· tracked since Jan 2026
Calls
2
Win Rate
0.0%
return
-35.6%
Calls 2 2 Posts tracked · 0.0/day
Calls
7d 0
30d 0
90d 0
Win Rate 0% Long 2 Short 0
Win Rate
7d 100%
30d 0%
90d 0%
Average Return -35.6% Long Return -35.6% Short Return -
Average Return
7d +6.1%
30d -22.3%
90d -9.4%
Visual Insights Log in to see more
Result
Result
Sort
Theme Stance
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Jan 09
$2.03
-52.3%
BLNE benefits from Trump mortgage bond buying
The author argues BLNE is a low-float mortgage lender positioned to benefit from a Trump announcement to buy $200 billion in mortgage bonds to drive down rates, which should heat up the housing market and trigger a sector rotation. The author cites BLNE's no-debt balance sheet, insider buying, record revenue after the October rate cut, an active blockchain HELOC program with 5-star reviews, tokenized real estate, a CEO pledge of no further dilution, and positive cash flow. The stock has been beaten down by a tough housing market but is improving since launching its new product and paying off debt, and the author expects it to run as peers like OPEN already have. Main stated risk is the prior tough housing market that depressed the stock.
Other
Long
Jan 05
$3.95
-19.0%
Undervalued debt-free growth with Wegovy oral pill catalyst
The author argues LifeMD is undervalued because it generated $260 million in trailing revenue, paid off all debt, is cash-flow positive, and trades at a $185 million market cap near a 52-week low. The company received approval to supply Novo Nordisk's oral Wegovy pill, which the author treats as a concrete positive catalyst. The author bought 10,000 shares based on this view.
GLP-1 / Obesity
Showing 2 of 2 calls · sorted by mentions

u/Get_rch_or_try_dyin has 2 trade ideas tracked on Buzzberg across 2 tickers since January 2026. Most covered: LFMD, BLNE.

Historical call returns are modeled from recorded ideas and stored prices, not actual brokerage portfolio returns. Check the evaluated call set and horizon; past results do not establish future prediction accuracy. Explore our data and methodology